TMEM107

Chr 17AR

transmembrane protein 107

Also known as: GRVS638, JBTS29, MKS13, PRO1268

This gene encodes a transmembrane protein and component of the primary cilia transition zone. The encoded protein regulates ciliogenesis and ciliary protein composition. Human fibroblasts expressing a mutant allele of this gene exhibit reduced numbers of cilia, altered cilia length, and impaired sonic hedgehog signaling. In human patients, different mutations in this gene cause different ciliopathies, including Meckel-Gruber syndrome and orofaciodigital syndrome. [provided by RefSeq, May 2017]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 1.903 OMIM phenotypes
Clinical SummaryTMEM107
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
34 unique Pathogenic / Likely Pathogenic· 164 VUS of 318 total submissions
📖
GeneReview available — TMEM107
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.90LOEUF
pLI 0.000
Z-score -0.91
OE 1.36 (0.821.90)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
1.09Z-score
OE missense 0.67 (0.540.83)
58 obs / 86.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?1.36 (0.821.90)
00.351.4
Missense OE?0.67 (0.540.83)
00.61.4
Synonymous OE?0.86
01.21.6
LoF obs/exp: 10 / 7.3Missense obs/exp: 58 / 86.6Syn Z: 0.68

This gene — mechanism propensity

DN
0.6453th %ile
GOF
0.75top 25%
LOF
0.3066th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

318 submitted variants in ClinVar

Classification Summary

Pathogenic25
Likely Pathogenic9
VUS164
Likely Benign70
Benign30
Conflicting16
25
Pathogenic
9
Likely Pathogenic
164
VUS
70
Likely Benign
30
Benign
16
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
6
2
17
0
25
Likely Pathogenic
1
0
8
0
9
VUS
4
40
120
0
164
Likely Benign
0
0
47
23
70
Benign
0
0
28
2
30
Conflicting
16
Total114222025314

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

20 pathogenic / likely-pathogenic (of 33) ClinVar copy-number / structural variants overlap TMEM107 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

TMEM107 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →